Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialPubMed

[Morphological characteristic of wound healing process in patients with diabetic purulent-necrotic foot lesion treated with oxytocin].

Gavrilenko VG., Esipov VK., Sivozhelezov KG.

Randomized Controlled Trial with a reported sample of 90 on Diabetic Foot, Chronic Wound, published in Morfologiia (2003) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
Morfologiia (2003)
Country
Russia (Federation)
Reported sample size
90
Source database
PubMed
PMID
14870468

Abstract (original English)

Wound healing was studied in 90 patients with "diabetic foot" receiving complex treatment which included oxytocin (40 patients) or did not use it (50 patients). Intraarterial injection or local application of oxytocin resulted in significant differences of wound process characteristics as compared with those ones in control group. The necrobiotic and necrotic changes in the tissues of skin, subcutaneous adipose tissue and skeletal muscles, located within the purulent-necrotic foci, were less expressed. The number of sludged capillaries, as well as of arterioles and venules with the signs of microthrombosis, was significantly decreased. Simultaneously, the regenerative potential of endotheliocytes, fibroblasts and adventitial cells was increased, showing a significant stimulation of their DNA-synthesizing capacity. The histological findings obtained indicate that the introduction of oxytocin in complex treatment activates the processes of vasculogenesis, proliferation of endotheliocytes anf histiocytes, that, in turn, results in the effective clearance of the wound and optimal granulation tissue formation.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
Administration, TopicalAdultAgedAged, 80 and overAmputation, SurgicalCombined Modality TherapyDNADiabetic FootFemaleHumans

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research